Increasing prevalence of appendicitis is set to propel the growth of the global appendicitis market at a CAGR of 4.10%

Pune, India, June 2022, MRFR Press Release/- Market Research Future has Published a Cooked Research Report on the Global Appendicitis Market.

Global Appendicitis Market Highlights

The Global Appendicitis Market is estimated to be valued at USD 10.19 Billion by 2032 and is expected to register a CAGR of 4.10% during the forecast period (2023-2032).

The acute segment dominated the global appendicitis market, by type, and is projected to reach USD 9,518.69 Million owing to the cost-effectiveness of the product. However, the chronic segment is projected to be the fastest-growing segment during the forecast period.

North America dominated the market, accounting for the largest share of the market in 2018, and the regional market is expected to register a CAGR of 39.8% during the review period. The European market was the second largest in 2018. The market is projected to reach USD 3,484.27 Million, with Italy being the leading market.   

Segment Analysis

The global appendicitis market has been segmented based on type, diagnosis & treatment, end-user, and region. Based on type, the market has been divided into acute and chronic. The acute segment held the majority market share in 2018. However, the chronic segment is anticipated to be the fastest growing.

Based on diagnosis and treatment, the market is further sub-segmented as diagnosis and treatment. The diagnosis segment is further sub-segmented as ultrasound imaging, CT scan, and others. The diagnosis segment held the majority market share in 2018. Treatment segment is further sub-segmented into antibiotics and appendectomy. However, the treatment segment is expected to exhibit the highest CAGR.

On the basis of end-user, the market has been divided into hospitals & clinics and diagnostic centers. The hospitals & clinics segment accounted for the larger market share in 2018. However, the diagnostic centers segment is expected to exhibit the higher CAGR during the forecast period.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Appendicitis Market Research Report

Market Players

Market Research Future (MRFR) recognizes Johnson & Johnson Services Inc (US), Pfizer Inc (US), Lupin (India), Siemens (Germany), Koninklijke Philips NV (Netherlands), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Cook (US), Medtronic (Ireland), Teva Pharmaceutical Industries Ltd (Israel) as the key players in the global appendicitis market.

Regional Analysis

Geographically, the global appendicitis market has been segmented into North America, Europe, Asia-Pacific, and Middle East & Africa. As per MRFR analysis, North America was the largest market for appendicitis in 2018 and is expected to remain dominant during the review period. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. The growth of the medical device industry is a major driving factor for the growth of the appendicitis market in Europe. Italy accounted for the largest market share in 2018.

Key Findings of the Study:

• The global appendicitis market is projected to reach over USD 10.19 Billion by 2032 at a 4.10% CAGR during the review period of 2023 to 2032.

• North America accounted for the largest market share with the US being the major contributor to the growth of the market.

• The acute type segment is projected to register the highest CAGR of 4.18% during the forecast period owing to the rising prevalence of appendicitis.

• Key manufacturers are adopting geographic expansions, corporate acquisitions, and product launches as growth strategies. Moreover, they are focusing on e-commerce for distribution.